Detroit Free Press

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam – Generic Xanax(R) – for Rapid Anxiety Relief

ESTERO, FLORIDA / ACCESS Newswire / January 20, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a biopharmaceutical company developing multi-faceted patent-pending ...

NeutronX Files Provisional Patent for Autonomous AI-Powered Government Contract Bidding System and Advances NeutronX Bidding Engine v2.4 in Connection with Ne…

NeutronX Corporation ("NeutronX"), an advanced artificial intelligence infrastructure company, today announced that it has ...

Enertopia Announces Filing of Patent-Pending Oxyhydrogen System

Enertopia Corp. (OTCQB: ENRT) (CSE: ENRT) ("Enertopia'' or the "Company") announces corporate update.The Company has filed a non-provisional patent application with the United States Patent and ...
Nasdaq

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the active ingredient in Dramamine®. Meclizine was the top-prescribed antiemetic ...
The Indianapolis Star

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam – Generic Xanax(R) – for Rapid Anxiety Relief

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized anxiety disorders Alprazolam, sold under the brand name Xanax® among others, ...